Ease the Squeeze: Pharmacotherapy of Vasospasm in Subarachnoid Hemorrhage
Speaker Heading link
![Andrew J. Webb, PharmD, BCCCP](https://c4conference.uic.edu/wp-content/uploads/sites/424/2024/05/Webb-Headshot2-1090x1635.jpg)
Speaker:
Andrew J. Webb, PharmD, BCCCP
Clinical Pharmacy Specialist, Neurocritical Care
Massachusetts General Hospital
Session Information Heading link
A Knowledge-Based Activity
ACPE UAN # 0016-0000-24-060-L01-P, 1.0 contact hours
1.0 contact hour CNE
Learning Objectives:
- Define cerebral vasospasm after aneurysmal subarachnoid hemorrhage and how it is diagnosed.
- Describe the evidence and rationale for the available pharmacotherapeutic options for cerebral vasospasm.
- Review how adjunctive diagnostic modalities can be used to detect and monitor treatment response in cerebral vasospasm.
Speaker Disclosures
Dr. Andrew Webb is a consultant for Acasti Pharma, Inc. All of the relevant financial relationships listed for Dr. Andrew Webb have been mitigated through peer review. See Speakers page for all other disclosures.
Modified on June 28, 2024